Targeting Replication Stress for Glioma Stem Cell Specific Cytotoxicity

نویسندگان

چکیده

Abstract AIMS Glioma stem cells (GSC) show high levels of DNA replication stress and exhibit abnormal S phase in comparison to differentiated, non GSC tumour cells. We investigated the phenotypes mechanism specific cytotoxicity following response inhibition with combined ATR/PARP (CAiPi). METHOD Paired enriched (‘GSC’) deplete differentiated (‘bulk’) populations were cultured from resected GBM specimens maintained neurobasal media growth factors or serum containing respectively. Cell viability, neurosphere clonogenic assays used assess whilst was interrogated utilising immunofluorescent repair foci, flow cytometry fibre assay. CAiPi consisted VE821 (ATRi) Olaparib (PARPi). RESULTS reduced rates alterations cell cycle profile demonstrate extreme sensitivity CAiPi. resulted significantly elevated 53BP1 nuclear bodies indicating genomic under- replication, however did not preferentially reduce fork speed compared non-GSC. Analysis structures revealed an increase new origin firing dependent upon PARP trapping. by roscovitine induced firing, suggesting important role dysregulated response. is also potently radiosensitising CONCLUSION Taken together these data suggest that are vulnerable dysregulation which results under-replication their genome reliance G1 resolution damage. propose attractive therapeutic strategy for translation clinic.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

TLR9 is critical for glioma stem cell maintenance and targeting.

Understanding supports for cancer stem-like cells in malignant glioma may suggest therapeutic strategies for their elimination. Here, we show that the Toll-like receptor TLR9 is elevated in glioma stem-like cells (GSC) in which it contributes to glioma growth. TLR9 overexpression is regulated by STAT3, which is required for GSC maintenance. Stimulation of TLR9 with a CpG ligand (CpG ODN) promot...

متن کامل

Tumor cell-specific cytotoxicity by targeting cell cycle checkpoints

Cell cycle checkpoints act to protect cells from external stresses and internal errors that would compromise the integrity of the cell. Checkpoints are often defective in cancer cells. Drugs that target checkpoint mechanisms should therefore be selective for tumor cells that are defective for the drug-sensitive checkpoint. Histone deacetylase inhibitors typify this class of agents. They trigger...

متن کامل

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B

Glioblastoma (GBM) ranks among the most lethal cancers, with current therapies offering only palliation. Inter- and intrapatient heterogeneity is a hallmark of GBM, with epigenetically distinct cancer stem-like cells (CSCs) at the apex. Targeting GSCs remains a challenging task because of their unique biology, resemblance to normal neural stem/progenitor cells, and resistance to standard cytoto...

متن کامل

Transcriptional targeting of herpes simplex virus for cell-specific replication.

Tissue- or cell-specific targeting of vectors is critical to the success of gene therapy. We describe a novel approach to virus-mediated gene therapy, where viral replication and associated cytotoxicity are limited to a specific cell type by the regulated expression of an essential immediate-early viral gene product. This is illustrated with a herpes simplex virus type 1 (HSV-1) vector (G92A) w...

متن کامل

Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

Glioblastomas are deadly cancers that display a functional cellular hierarchy maintained by self-renewing glioblastoma stem cells (GSCs). GSCs are regulated by molecular pathways distinct from the bulk tumor that may be useful therapeutic targets. We determined that A20 (TNFAIP3), a regulator of cell survival and the NF-kappaB pathway, is overexpressed in GSCs relative to non-stem glioblastoma ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Neuro-oncology

سال: 2022

ISSN: ['1523-5866', '1522-8517']

DOI: https://doi.org/10.1093/neuonc/noac200.067